DaCapo Brainscience
DaCapo Brainscience is a biotechnology company focused on developing the first disease-modifying therapies for neurodegenerative diseases. With a mission centered on addressing the challenges of conditions such as Parkinson's disease, DaCapo Brainscience leverages deep expertise in the field to pioneer innovative treatments. The company's approach includes targeting the accumulation of specific proteins in the brain, which are associated with the progression of neurodegenerative diseases. DaCapo Brainscience is committed to advancing research and development to offer new paths forward for patients affected by these conditions. The team consists of professionals with extensive experience in biotechnology, working towards making significant contributions to the field of neuroscience.
Domain
dacapobrain.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$20.0M
Founded
2020
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does DaCapo Brainscience use?+
DaCapo Brainscience uses 16 technologies including Astra, Gutenberg, Spectra.
What industry is DaCapo Brainscience in?+
DaCapo Brainscience operates in the Biotechnology industry.
Where is DaCapo Brainscience based?+
DaCapo Brainscience is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026